Pharma Industry
Industry: Email Alert RSS FeedOmeprazole. (Pharma in Brief).(Mylan Pharmaceuticals launches delayed release capsules)(Brief Article)
Chemical Market Reporter, August, 2003
OMEPRAZOLE Mylan Laboratories Inc., through its wholly owned subsidiary Mylan Pharmaceuticals Inc., has launched 10 mg and 20 mg omeprazole delayed release capsules. The drug is the generic version of AstraZeneca PLC's Prilosec.
Premium Content Partnership |
HighBeam Research provides an in-depth online archive library of reference works.
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
